Duke named to national network studying rare diseases
Duke University is one of six new clinical sites in the country that will participate in a recenty formed Undiagnosed Diseases Network established by the National Institutes of Health.
The network is
Duke, WakeMed Agree to Guidelines to Explore Clinical Collaborations
Duke Medicine and WakeMed Health & Hospitals establish a framework for discussions on future clinical collaborations.
This week's faculty spotlight shines o
It's here!
RFA: Comparative Health System Performance in Accelerating PCOR Dissemination (U19)
The AHRQ invites applications for Centers of Excellence to identify, classify, track, and compare healthcare delivery systems ranging from integrated delivery systems to Accountable Care
FOA: Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases
The NIH and NIDDK are supporting Exploratory/Developmental Research Grants (R21) proposing small scale or pilot and feasibility clinical and translational research studies, including epid
FOA: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
The NIDDK, NIAAA and ODS are encouraging R21 applications involving secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases